The CRO level services arm of Kerlo Research, known as ‘Q5’ provides an extensive array of services to entities within the pharmaceutical, biotech, and medical device sectors.
Formed through the collaboration of two renowned companies, the renowned site management organization, Kerlo Research Inc. and DM Clinical Research, which both have extensive backgrounds in clinical site management, Q5 Clinical is distinguished by its proven expertise, having completed numerous trials for the largest names in the pharmaceutical world. As the landscape of biotechnology and pharmaceuticals has undergone swift transformations, Q5 Clinical is dedicated to enhancing the conventional CRO paradigm. We are ought to tailor unique and specialized solutions that cater to the distinct needs of each of our clients.
Q5 Services
Serving as a Clinical Research Organization, Q5 provides a range of services that include, but are not limited to, the following areas:
- Clinical Trial Planning and Management
- Study Design and Feasibility
- Site Selection
- Regulatory Services
- Monitoring Services
- Data Management
- Patient Recruitment
- Medical Writing
- Drug Safety and Pharmacovigilance
Our team is composed of specialized subject matter experts and a cadre of highly skilled industry veterans. This wealth of expertise empowers us to tailor our offerings to each unique project, ensuring we meet and surpass our clients’ expectations.
Our reputation as dependable partners shines through in the intricate and fascinating pathways of development that our clients navigate in their research endeavors.
At Q5, we collaborate closely with your team to outline goals and devise cutting-edge strategies. We ensure there are clear Key Performance Indicators (KPIs) to measure progress. Our seasoned experts offer their skills to enhance your technological processes and operational efficiency.
Our team includes distinguished physicians, each with hands-on experience in conducting clinical studies across different therapeutic areas. They have served as Principal Investigators and Sub Investigators, enrolling patients and managing studies. Their expertise in clinical research proves invaluable in advisory roles, guiding our work on every project and offering creative solutions for complex challenges.
We cater our services to the specific requirements of each clinical project, whether as stand-alone options or under the full-service CRO model. This includes developing and commercializing new drugs and therapies in the US and globally. Additionally, we offer subcontracting support for major CROs, assisting with specific aspects of their projects they wish to outsource to Q5.
Q5’s adaptable strategies cater to businesses of all sizes
At Q5, we recognize the global nature of the industry, but we also understand that small to mid-sized companies may operate on a local scale due to limitations in expertise, financial capacity, or infrastructure.
A strategic partnership with Q5 equips these firms with the advantages of a CRO that aligns with their vision and has the necessary expertise and reach for expansion into multiple international markets. Our balanced approach delivers unique cost-saving benefits.
Statistical data has demonstrated this method accelerates the growth of small firms, yielding a 22% increase in trial results. We are committed to providing the highest quality services, while maintaining a flexible and responsive approach. Our goal is to be your partner in clinical research, not just another vendor.
